Graphite Bio is a clinical-stage, next-generation gene editing company focused on developing curative therapies for patients who have serious, life-threatening genetic diseases. The company’s platform harnesses the natural cellular process of homology directed repair (HDR) and targeted DNA integration to precisely repair genetic defects at their source. Graphite Bio is leveraging its differentiated platform to advance a portfolio of transformative genetic treatments with potential for saving and dramatically improving patients’ lives.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $195.749985M
Founded date: 2020
Investors 2
| Date | Name | Website |
| 17.08.2021 | Logos Capi... | logoscapit... |
| - | RA Capital... | racap.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.09.2020 | Series A | $45M | - |
| - | Series B | $150.74998... | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 15.11.2023 | The apparently strong correlation between biotech stocks and... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 06.01.2023 | A tiny biotech just suffered a safety scare in a gene-editin... | Graphite Bio CEO Josh Lehrer Graphite Bio This story is available exclusively to Insider subscribers... | businessin... |
| 25.06.2021 | With sickle cell disease study in sight, Graphite Bio draws ... | Graphite Bio’s technology precisely finds and replaces genes, offering potential cures for genetic d... | medcitynew... |
| 15.03.2021 | Graphite Bio : Secures $150 Million Series B Financing to Ad... | Graphite Bio, a next-generation gene editing company focused on therapies that harness targeted gene... | marketscre... |
| 15.03.2021 | Graphite Bio, Inc. announced that it has received $150.74998... | On March 15, 2021, Graphite Bio, Inc. closed the transaction. The company has received funding in se... | marketscre... |
| 15.03.2021 | Daily funding roundup - March 15th, 2021 | Stripe landed $600M; ElevateBio raised $525M; Graphite Bio secured $150M Airtable: Airtable is a Sa... | vator.tv/n... |
| 24.02.2021 | Graphite Bio Expands Leadership Team with Appointment of Jer... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 24, 2021-- Graphite Bio, a next-generation gene e... | oaoa.com/n... |
| 16.09.2020 | Gene-editing biotech startup Graphite Bio launches with $45 ... | CRISPR-Cas9 gene editing has transformed the biotechnology landscape due to its ability to specifica... | techstartu... |
| 16.09.2020 | Graphite Bio Launches with $45M Series A | SOUTH SAN FRANCISCO, CA, Graphite Bio announced a $45 million Series A financing led by founding i... | vcnewsdail... |
| - | With sickle cell disease study in sight, Graphite Bio draws ... | Graphite Bio’s technology precisely finds and replaces genes, offering potential cures for genetic d... | medcitynew... |
Show more